Male Urinary Incontinence Market To Reach $10.02 Billion By 2030

Male Urinary Incontinence Market Growth & Trends 

The global male urinary incontinence market size is anticipated to reach USD 10.02 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.87% from 2023 to 2030. Rapid advancements in technology, an increasing demand for minimally invasive procedures, rising healthcare expenditure, and advancements in non-absorbent & absorbent products drive industry growth. Also, the increasing prevalence of chronic diseases is anticipated to expand the market for male urinary incontinence globally.

One of the key factors driving market expansion is the rapid technical advancements linked to incontinence. Synthetic MS for Proton Pump Inhibitors (PPI) has risen in popularity in recent years since it is less expensive, less intrusive, and does not require mechanical manipulation during voiding. For example, the innovation of fit and efficient pouching systems and associated accessories to improve patient’s quality of life is projected to drive the market.

Boston Scientific Corporation, Coloplast Corp., and Teleflex Incorporated are a few of the key players in the market that are investing significantly in research and development activities to introduce new products. For instance, Coloplast Corp. launched its innovative male catheter Luja in February 2023, making it the first and only male catheter with over 80 micro-holes designed to address the primary urinary tract infection risk factor linked with intermittent catheterization.

Despite its potential for expansion, the male urinary incontinence industry faces obstacles such as a lack of knowledge and inconsistent reimbursement rules. Technological developments, better patient education, and continuous research, on the other hand, are projected to stimulate the development of more effective and less intrusive treatment alternatives. Furthermore, the combination of digital health solutions and telemedicine may help improve access to diagnosis and treatment for males with urine incontinence.

 Request a free sample copy or view report summary: Male Urinary Incontinence Market Report

Male Urinary Incontinence Market Report Highlights

• In 2022, the absorbents product segment dominated the male urinary incontinence industry with a revenue share of 70.60%. The market for absorbent devices has experienced several technological and design developments, with the goal of providing consumers with improved ease of use and reliability

• Based on incontinence type, the urge urinary incontinence segment held the dominant revenue share of around 57.18 % in 2022, owing to the increasing incidences of age-related illnesses such as prostate problems, which may cause prostate issues such as benign prostatic hyperplasia or prostate cancer that can lead to bladder discomfort and, as a result, urgent urine incontinence

• In terms of usage, the disposable segment held the largest market share of around 68.93% in 2022. Disposable products are very easy to use, as they allow users to conveniently dispose of used products and replace them with new ones

• With regard to distribution channels, the offline store segment held the largest market share of 54.26% in 2022. Local customers who prefer to purchase these products in person rather than waiting for their online delivery benefit from offline facilities

• Among end-users, hospitals held a majority share of 64.77% of the market in 2022. Hospitals are critical in educating patients about urine incontinence, its causes, and treatment choices.In addition, in severe cases of urine incontinence, hospitals may offer surgical therapies such as sling surgery, artificial urinary sphincter implantation, and others

• Europe dominated the global market for male urinary incontinence with a revenue share of 49.81% in 2022. Growing demand for minimally invasive surgeries, along with rising government initiatives for improving the healthcare infrastructure, are among the key factors driving regional market growth. In addition, technological advancements and innovation of new non-invasive techniques will create lucrative opportunities for the segment in the coming years

Male Urinary Incontinence Market Segmentation

Grand View Research has segmented the global male urinary incontinence market on the basis of product, incontinence type, usage, distribution channel, end-use, and region:

Male Urinary Incontinence Product Outlook (Revenue, USD Million, 2018 - 2030)

• Non-Absorbents

  • Urinary Catheters

    • Foley Catheters

    • External Catheters

  • Drainage Bags

  • External Compression Devices/Penile Clamps

  • Artificial Urinary Sphincter

  • Others

• Absorbents

  • Underwear & Briefs

  • Drip Collectors & Bed Protectors

  • Pads & Guards

Male Urinary Incontinence Type Outlook (Revenue, USD Million, 2018 - 2030)

• Stress Urinary Incontinence

• Urge Urinary Incontinence

• Overflow Incontinence

• Functional Urinary Incontinence

• Mixed Urinary Incontinence

Male Urinary Incontinence Usage Outlook (Revenue, USD Million, 2018 - 2030)

• Reusable

• Disposable

Male Urinary Incontinence Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Offline Stores

• Online Channels

Male Urinary Incontinence End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics

• Homecare

• Others

Male Urinary Incontinence Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Male Urinary Incontinence Market

• Essity

• Kimberly-Clark Worldwide Inc.

• Attends Healthcare Products, Inc.

• ABENA

• Coloplast Corp.

• Teleflex Incorporated

• Boston Scientific Corporation

• Ontex Healthcare

• PAUL HARTMANN AG

• First Quality

• Medline

• BD

• Hollister Incorporated

• Cardinal Health